Health Care Equipment & Services

Bruls Annette’s modest 109‑share sale at Edwards Lifesciences signals routine liquidity needs, not a warning—insider buying stays strong and the company’s growth outlook remains solid.

Oncology Institute insider buying spikes: director Chernett Jorey’s latest 15,000‑share purchase signals confidence in value‑based care growth and a potential undervalued upside for long‑term investors.

Aziz Kabeer’s July 10 insider purchase signals confidence in Elevance Health’s growth—boosting investor sentiment amid expanding Medicare & community‑health initiatives.

Mark Hancock’s July 10b5‑1 sales show disciplined insider cash‑management, not panic, while PACS Group expands into India’s micro‑ATM market—an insight for savvy investors.

Discover why Elevance Health’s July 8 insider sale is routine—RSU vesting, tax needs, and solid fundamentals keep the stock poised for growth.

Edwards Lifesciences insiders buying RSUs and options signal confidence in its growth, boosting investor confidence in high‑growth heart‑valve tech.

Insider buying at Streamex Corp shows confidence in a low‑priced tech stock—2026 purchases suggest future upside despite current decline.

Explore how insider trading and new equity awards at Establishment Labs Holdings impact investor confidence and future growth prospects.

TruBridge’s final sell‑off by Pinetree Capital at $26.25 per share seals its merger into IKS Health, ending an era of independent growth and signaling new opportunities for investors in the healthcare‑tech consolidation wave.

Bank of America’s small stake in Bluejay Diagnostics signals institutional confidence, while insider buying suggests management sees hidden value—what it means for investors.